v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash $ 1,889,291 $ 501,295
Prepaid expenses and other current assets 208,661 266,862
Current assets held for sale 9,603,157 9,552,454
Total current assets 11,701,109 10,320,611
Right of use assets, net 7,820 22,982
Total assets 11,708,929 10,343,593
Current liabilities:    
Accounts payable and accrued liabilities 523,782 337,038
Accrued employee compensation 939,716 912,103
Other current liabilities 7,820 22,982
Current liabilities held for sale 1,277,934 7,476,254
Total current liabilities 2,749,252 8,748,377
Non-current liabilities held for sale 6,148,134  
Long-term debt   3,486,141
Total liabilities 8,897,386 12,234,518
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit):    
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 372,976 and nil shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively 3,730  
Common stock, $0.001 par value, 75,000,000 shares authorized; 5,147,204 and 3,877,695 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively 5,147 3,878
Additional paid-in capital 393,896,728 386,368,222
Accumulated deficit (391,094,062) (388,263,025)
Total stockholders’ equity (deficit) 2,811,543 (1,890,925)
Total liabilities and stockholders’ equity (deficit) $ 11,708,929 $ 10,343,593